Diabetic Mastopathy: Adjunctive Use of Ultrasound and Utility of Core Biopsy in Diagnosis

Andrews-Tang, Denise; Diamond, Arthur B.; Rogers, Lowell W.; Butler, Duncan

doi:10.1046/j.1524-4741.2000.99073.x

Cited by 45 publications

(58 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Typically, the lesion results in a hypoechoic formation, more or less irregular contours responsible for a marked attenuation of ultrasound [4,8,10]. These anomalies ultrasound were found in our patient.…”

supporting

confidence: 54%

See 1 more Smart Citation

Diabetic Mastopathy, Diagnoses and Management

Ragmoun¹,

Ajili²,

Daadoucha³

2017

J Cytol Histol

View full text Add to dashboard Cite

Diabetic mastopathy (DM) is a pathological entity of recent description, it is rare and benign; occurring in young patients with type I diabetes, or having an autoimmune disease. Clinically, she simulates breast cancer. Radiological examinations are not very informative. The diagnosis of certainty is histological. Through an observation of (DM) occurred in a diabetic patient, under insulin for 14 years and carrying multiple degenerative complications, we recall the clinical aspects, radiological and evolutionary of this affection.

show abstract

supporting

confidence: 54%

“…These anomalies ultrasound were found in our patient. Breast MRI has been tested in limited cases; but it does not differentiate the (DM) from a possible breast cancer [3,10].…”

mentioning

confidence: 99%

Diabetic Mastopathy, Diagnoses and Management

Ragmoun¹,

Ajili²,

Daadoucha³

2017

J Cytol Histol

View full text Add to dashboard Cite

show abstract

“…Cellular material from fineneedle aspiration biopsy (FNAB) shows usually scarce cellularity, making the cytological diagnosis difficult (2). Ultrasound guided core needle biopsy, in the majority of the cases, is helpful in making the diagnosis but, in some situations, it is necessary to undergo surgical biopsy (6,7).…”

mentioning

confidence: 99%

Regression of the fibrous disease of the breast in a non-diabetic woman after pregnancy and breastfeeding

Pereira

Segura

Santos

et al. 2007

Arq Bras Endocrinol Metab

View full text Add to dashboard Cite

Fibrous mastopathy, also known as diabetic mastopathy and lymphocytic mastopathy, may mimic breast cancer at the physical examination, mammography, and ultrasound. We report a case of a woman who presented a non-tender mass clinically suggestive of breast carcinoma; however, the fine-needle aspiration cytology indicated atypia and the core needle biopsy revealed lymphocytic mastopathy. The magnetic resonance imaging of the breast showed a lesion with benign features. It was not demonstrated diabetics mellitus and autoimmune diseases. The patient got pregnant, breastfed, and it was observed the progressive regression of the lesion, with complete disappearance of the solid mass. Three years and three months later, there was no palpable mass at the clinical examination and ultrasound. In conclusion, fibrous mastopathy shall be considered for all breast lesions, regardless of the diagnosis of diabetes mellitus. Once a definitive diagnosis of this pathology is reached, it is recommended clinical, imaging studies and fine-needle aspiration biopsy follow-up of the patient, avoiding unnecessary surgical procedures. RESUMO Regressão de Mastopatia Fibrótica após Gravidez e Amamentação em uma Mulher Não Diabética.A mastopatia fibrótica, também conhecida como mastopatia diabética e mastopatia linfocítica, pode, ao exame clínico, mamografia e ultra-som, simular um carcinoma mamário. Descrevemos o relato de uma mulher na qual o nódulo foi inicialmente suspeito de carcinoma mamário, mas o diagnóstico pela punção aspirativa com agulha fina foi de atipia, e o com biópsia com agulha grossa foi de mastopatia linfocítica. A ressonância magnética da mama mostrou a lesão com características de benignidade. Não foram demonstradas diabetes mellitus e doenças auto-imunes. A paciente engravidou, amamentou e foi observada regressão progressiva da lesão, com desaparecimento da mesma. A paciente persiste sem lesão na mama ao exame clínico e de ultra-som após acompanhamento de três anos e três meses. Em conclusão, a mastopatia fibrótica deve ser considerada para todas as lesões de mama, mesmo em pacientes sem diabetes mellitus. Quando o diagnóstico definitivo da patologia for realizado, é recomendável o acompanhamento da paciente com estudos clínicos e de imagem e biópsia com agulha fina, evitando-se procedimentos cirúrgicos desnecessários.

show abstract

“…Typically, the lesion results in a hypoechoic formation, more or less irregular contours responsible for a marked attenuation of ultrasound (Williams et al, 1995;Andrews-Tang et al, 2000;Murakami et al, 2009). These anomalies ultrasound were found in our patients.…”

Section: Observationmentioning

confidence: 99%